Clinical evidence for a graft-versus-tumour effect following allogeneic HSCT for t(8;13) atypical myeloproliferative disorder

Bone Marrow Transplantation

Volumn 44, Issue 3, 2009, Pages 197-199

  Townsend, W ^a   Cross, N C P ^b   Waghorn, K ^b   Somana, K ^a   Ramsay, A ^a   Thomson, K ^a   Peggs, K ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; IDARUBICIN; METHOTREXATE; STEROID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CUTANEOUS GRAFT VERSUS HOST REACTION; DRUG MEGADOSE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MYELOPROLIFERATIVE DISORDER; NIGHT SWEAT; ORAL GRAFT VERSUS HOST REACTION; PRIORITY JOURNAL; SPLENOMEGALY; THROMBOCYTE COUNT; TREATMENT RESPONSE; TRISOMY; WHOLE BODY RADIATION;

ADULT; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 8; GRAFT VS TUMOR EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MYELOPROLIFERATIVE DISORDERS;

EID: 68949105833     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.448     Document Type: Article

References (8)

1. Macdonald D, Aguiar R, Mason P, Goldman J, Cross N. A new Myeloproliferative disorder associated with chromosomal translocations involving 8p11: A review. Leukaemia 1995; 9: 1628-1630.
2. Macdonald D, Sheerin S, Cross N, Spencer A, Goldman J. An atypical myeloproliferative disorder with t(8;13)(p11;q12): A thrid case. B J Haem 1994; 86: 879-880.
3. Reiter A, Sohal J, Kulkarni S, Chase A, Macdonald D, Aguiar R et al. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome. Blood 1998; 5: 1735-1742.
4. Macdonald D, Reiter A, Cross N. The 8p11 myeloproliferative syndrome: A distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematol 2002; 107: 101-107.
5. Chase A, Grand F, Cross N. Activity of TK1258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome. Blood 2007; 110: 3729-3734.
6. Suzan F, Guasch G, Terre C, Garcia I, Bastie JN, Maarek O et al. Long-term complete haematological and molecular remission after allogenic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12). B J Haem 2003; 121: 312-314.
7. Sahin F, Sercan Z, Ertan Y, Ocakci S, Ay E, Vural F et al. Rapid transformation of atypical myeloproliferative disorder with consistent t(8;13) to B-cell acute lymphoblastic leukaemia: A case report. Haematology 2007; 12: 489-492.
8. Cross NC, Melo JV, Feng L, Goldman JM. An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia. 1994; 8: 186-189.